Lacosamide Tablet, Film Coated
Product Images NDC 0904-7246

8 FDA label images from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 0904-7246). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Laco-str (Laco Str)

Laco-str (Laco Str)
Chemical structure of Lacosamide, showing its molecular composition including an amide group, methoxy group, and phenyl ring. The diagram represents the active ingredient Lacosamide as used in the oral film-coated tablet form by Major Pharmaceuticals.*
FDA Label Image

Laco-fig1.jpg (Laco Fig1)

Laco-fig1.jpg (Laco Fig1)
A bar graph showing the median percent reduction in seizure frequency per 28 days from baseline to the maintenance phase by dose in studies 2, 3, and 4. The x-axis lists placebo and various doses of lacosamide (200 mg, 400 mg, 600 mg), with corresponding sample sizes. The y-axis shows seizure reduction percentage from 0% to 45%. The graph indicates higher seizure reductions in lacosamide groups compared to placebo, with statistical significance noted by asterisks.*
FDA Label Image

Laco-fig2.jpg (Laco Fig2)

Laco-fig2.jpg (Laco Fig2)
A line chart titled "Proportion of Patients by Responder Rate for Lacosamide and Placebo Groups in Studies 2, 3, and 4." The x-axis represents the percent of patients from 0 to 100, and the y-axis shows responder rate (equal to or greater) ranging from -100% (worsening) to 100% (improvement). The chart compares Placebo (N=359) and Lacosamide at doses of 200 mg/day (N=267), 400 mg/day (N=466), and 600 mg/day (N=202), illustrating patient response rates across these groups.*
FDA Label Image

Laco-fig3-a (Laco Fig3 A)

Laco-fig3-a (Laco Fig3 A)
A survival curve plot comparing the proportion of patients over time (days) between those treated with Lacosamide and those given a placebo. The graph includes the number of patients at risk for each group at various time points and statistical values such as p-value, hazard ratio, and confidence interval.*
FDA Label Image

50mg Carton Label (062a789f 52f0 482b 9ec0 2ba3ac1572ec 03)

50mg Carton Label (062a789f 52f0 482b 9ec0 2ba3ac1572ec 03)
Label for Lacosamide 50 mg film-coated tablets by Major Pharmaceuticals. The label indicates it is a Unit Dose package containing 60 tablets (6 x 10). It includes storage information, dispensing instructions, and notes that the drug product is from Ascend Laboratories. The label also displays the NDC 0904-7244-68 and a barcode at the bottom.*
FDA Label Image

100mg Carton Label (062a789f 52f0 482b 9ec0 2ba3ac1572ec 02)

100mg Carton Label (062a789f 52f0 482b 9ec0 2ba3ac1572ec 02)
Label for Lacosamide 100 mg oral film-coated tablets by Major Pharmaceuticals. This unit dose package contains 60 tablets (6 x 10). The label includes storage instructions, dispensing guidance, and a barcode, and indicates the product is prescription only and intended for institutional use only.*
FDA Label Image

150mg Carton Label (062a789f 52f0 482b 9ec0 2ba3ac1572ec 01)

150mg Carton Label (062a789f 52f0 482b 9ec0 2ba3ac1572ec 01)
Label for Lacosamide 150 mg tablets, USP, a human prescription drug by Major Pharmaceuticals. The label indicates unit dose packaging of 60 tablets (6 x 10), with a warning for pharmacists to dispense with a medication guide. Storage instructions and dosage information referencing the product insert are included. The label also contains NDC 0904-7246-68 and states the product is for institutional use only.*
FDA Label Image

200mg Carton Label (062a789f 52f0 482b 9ec0 2ba3ac1572ec 00)

200mg Carton Label (062a789f 52f0 482b 9ec0 2ba3ac1572ec 00)
Lacosamide 200 mg film-coated tablets label from Major Pharmaceuticals. This unit dose packaging contains 60 tablets (6 x 10). The label includes usage advisory for pharmacists, storage instructions, and states it is for prescription use only. The label also provides details on packaging and distribution, including barcodes and regulatory information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.